| Title |
Role of alpha-lipoic acid in the management of anemia in patients with chronic renal failure undergoing hemodialysis
|
|---|---|
| Published in |
International Journal of Nephrology and Renovascular Disease, August 2013
|
| DOI | 10.2147/ijnrd.s49066 |
| Pubmed ID | |
| Authors |
Gehad A El-Nakib, Tarek M Mostafa, Tarek M Abbas, Mamdouh M El-Shishtawy, Mokhtar M Mabrouk, Mohammed A Sobh |
| Abstract |
Anemia associated with chronic kidney disease is a serious complication necessitating expenditure of huge medical efforts and resources. This study investigates the role of alpha-lipoic acid (ALA) in end stage renal disease patients undergoing hemodialysis. By the virtue of its antioxidative effects, ALA is expected to act as an erythropoietin (EPO) adjuvant, and also has extended beneficial effects on endothelial dysfunction. |
Mendeley readers
The data shown below were compiled from readership statistics for 46 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Germany | 1 | 2% |
| Unknown | 45 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 10 | 22% |
| Student > Master | 6 | 13% |
| Student > Doctoral Student | 5 | 11% |
| Other | 5 | 11% |
| Student > Bachelor | 4 | 9% |
| Other | 10 | 22% |
| Unknown | 6 | 13% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 21 | 46% |
| Nursing and Health Professions | 6 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 4 | 9% |
| Agricultural and Biological Sciences | 4 | 9% |
| Unspecified | 2 | 4% |
| Other | 3 | 7% |
| Unknown | 6 | 13% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 December 2013.
All research outputs
#20,215,721
of 22,738,543 outputs
Outputs from International Journal of Nephrology and Renovascular Disease
#200
of 235 outputs
Outputs of similar age
#174,371
of 198,437 outputs
Outputs of similar age from International Journal of Nephrology and Renovascular Disease
#6
of 6 outputs
Altmetric has tracked 22,738,543 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 235 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 198,437 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.